Erbisol

Erbisol – immunomodulator.

Pharmacological properties

According to the instruction Erbisol contains biologically active peptides with a low molecular weight. They are capable to activate the controlling systems of an organism put by the nature which are responsible for elimination of the arising pathological changes.

Erbisol influences immune system, activating its immunomodulatory action. The immunomodulatory effect is implemented through macrophages who are responsible for recovery of the damaged cells and extermination of those from them which are not subject to recovery. Macrophages of different types recover balance between cellular and humoral immunity at oncological diseases, autoimmune and allergic processes. Researches proved reduction of frequency of necessary courses radio wave and chemotherapy when using Erbisol's at cancer patients.

Strengthening of action of antibiotics, the interferon entered into an organism belongs to additional effects of use of Erbisol, at the same time drug reduces their side effects.

Drug accelerates healing of erosion and mucous membrane ulcers in a digestive tract, increases recovery abilities of fabrics that also promotes healing of wounds, injuries, changes. Positive reviews about Erbisole are received from the stomatologists using him in therapy of a paradontosis and paradontit.

This means activates recovery processes in a liver at its virus, toxic or medicamentous defeat. As a result of its use the died cells of a liver are replaced with new. Antioxidant and membrane stabilizing effects of Erbisol normalize work of hepatocytes that at the level of an organism is shown by disappearance of painful, dispepsichesky and astenovegetativny manifestations.

At Erbisol's use in complex treatment of a diabetes mellitus he reduces autoimmune aggression, and activating macrophages, stimulates recovery of the damaged pancreas beta cells. Also positively drug influences the created diabetes mellitus complications in the form of neyropatiya, angiopatiya, trophic disturbances. Its use often leads to reduction of a dose of necessary insulin and to long remission of a disease. Positive influence on metabolism and improvement of contractility of heart improve quality of life of patients with a diabetes mellitus.

As the adaptogen drug is capable to increase protective properties of an organism. It joins in schemes of therapy of effects of ecological pollution and radiation defeats. Immunomodulatory action of Erbisol according to reviews begins to be shown for 5-7 day, reaching a maximum for 21 days, and keeping at the same level up to 10 days. The hepatoprotective effect is shown through 2-3 injections.

Release form

Erbisol produce in solution, in ampoules 1 and 2 ml.

Indications to Erbisol's use

In gastroenterology drug is used for treatment of various hepatitises and noninflammatory damages of a liver – hepatoses, hepatopathies, cirrhosis, at a peptic ulcer of a stomach or a 12-perstny gut, nonspecific ulcer colitis.

According to the instruction Erbisol is shown also at radioactive defeat and ecopathology.

Drug is used at a diabetes mellitus, nonspecific damages of lungs, an autoimmune thyroiditis, angiopatiya, at allergic and autoimmune defeats, a periodontal disease, paradontosis. Positive reviews about Erbisole are received from specialists in the field of gerontology. In surgery and traumatology drug is used for treatment of injuries, changes, wounds, trophic ulcers, decubituses.

In oncological practice Erbisol as drug of maintenance is used at chemotherapy, radio radiation therapy, for the prevention of innidiation at surgical interventions as a stimulator of antineoplastic protection.

Contraindications

Erbisol do not use at his individual intolerance and at children.

Application instruction of Erbisol

The drug is administered the next parenteral ways – intravenously, vnutriarterialno or intramusculary. For adults the dosage makes from 2 to 4 ml of drug every day, the course lasts 20 days. When the drug is administered once a day, it is desirable to do it before going to bed, in 3 hours after food. If two introductions are required, one of them will optimum do at 6-8 o'clock in the morning, in 1-1,5 hours prior to meal.

Allergic and autoimmune processes, gepatopatiitrebut introductions of 2 ml of Erbisol a day. In case of paradontit and a paradontosis the first 10 days do 4 ml, and the remained 10 days – on 2 ml.

At treatment by drug of a diabetes mellitus, autoimmune thyroiditis, peptic ulcer, nonspecific ulcer colitis, injuries, changes, cirrhosis, an asthenic syndrome the daily dose of drug makes 4 ml of 20 days in a row.

At oncological pathology for maintenance of radio wave therapy according to the instruction Erbisol appoint 2 ml in the morning and evening of 20 days in a row. In the period of chemotherapy the dose makes 2 ml in the evening within 12-25 days.

Side effects of Erbisol

Erbisol is according to reviews had well. In the first days of reception it can sometimes cause an aggravation of a chronic inflammation that is treated as a part of medical process. It is impossible to exclude risk of allergic reactions.